GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (LSE:ONT) » Definitions » Net Income From Continuing Operations

Oxford Nanopore Technologies (LSE:ONT) Net Income From Continuing Operations : £-149.8 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Oxford Nanopore Technologies's net income from continuing operations for the six months ended in Dec. 2023 was £-83.2 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was £-149.8 Mil.


Oxford Nanopore Technologies Net Income From Continuing Operations Historical Data

The historical data trend for Oxford Nanopore Technologies's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Net Income From Continuing Operations Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial -80.48 -73.15 -166.00 -83.41 -149.77

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only -121.60 -27.63 -55.79 -66.56 -83.21

Oxford Nanopore Technologies Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-149.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Nanopore Technologies (LSE:ONT) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (LSE:ONT) Headlines

No Headlines